Account-Based Marketing
for
Pharmaceutical & Biotech Companies.

Account selection - defining the ICP firmographics and building the target account list that aligns marketing and sales on the same opportunities

Account intelligence - researching each target account's priorities, pain points, and buying signals to inform personalised outreach

Multi-channel sequencing - building the LinkedIn, email, content, and event sequences that create multiple touchpoints with buying committees

Sales and marketing alignment - ensuring marketing content directly enables sales conversations with the accounts being targeted

Qualified pipeline from target accounts that match the ICP and deal size criteria, not just inbound volume

Shortened enterprise sales cycles from multi-stakeholder engagement that warms the buying committee before the first formal meeting

A repeatable ABM playbook that scales to new account cohorts without requiring the agency to rebuild the programme from scratch